Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Aug 06, 2026
AppLovin (APP) Q2 2026: 53% Revenue Growth Overshadowed by Miss, Shares Fall -16% to -20%

AppLovin (APP) Q2 2026: 53% Revenue Growth Overshadowed by Miss, Shares Fall -16% to -20%

Key Takeaways

  • Revenue: AppLovin reported Q2 2026 revenue of $1.92 billion, up 53% year-over-year but approximately $20 million below the consensus estimate of $1.94 billion.
  • Earnings per share: Adjusted EPS came in at $3.76, narrowly beating analyst expectations of $3.75. GAAP EPS was $3.77.
  • Profitability: Net income rose 55% year-over-year to $1.267 billion, while adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) climbed 58% to $1.61 billion with an 84% margin.
  • Guidance: Q3 2026 revenue guidance of $2.055 billion to $2.085 billion came in with a midpoint slightly below the $2.08 billion consensus, contributing to post-earnings selling pressure.
  • Market reaction: Shares plunged approximately 16% to 20% in after-hours trading, as investors reacted to the top-line miss and management's commentary about lighter-than-usual advertising model improvements during the quarter.
  • Shareholder returns: The company repurchased and withheld approximately 1.14 million shares for $551 million during the quarter, ending with $1.8 billion remaining under its buyback authorization.

Earnings Context and Why It Matters

AppLovin’s Q2 2026 results arrived at a critical juncture for the mobile advertising technology company. The firm operates both a demand-side platform called AppDiscovery and a supply-side platform called MAX. It has been one of the market’s standout growth stories, with shares having gained significantly over the past two years on the back of AI-driven advertising model improvements and rapid expansion into e-commerce advertising. Investors have come to expect consistent outperformance, and this quarter tested those elevated expectations. The revenue miss—even as growth remained above 50%—underscored how unforgiving the market has become for any deviation from high-growth trajectories in the ad tech sector.

Reported Results

AppLovin reported second-quarter revenue of $1.92 billion, representing 53% year-over-year growth from $1.26 billion in the prior-year period but falling short of the $1.94 billion Wall Street consensus. Adjusted earnings per share landed at $3.76, edging past the $3.75 analyst estimate, while GAAP EPS reached $3.77. Net income from continuing operations increased 64% year-over-year to $1.267 billion. Adjusted EBITDA surged 58% to $1.61 billion, producing an adjusted EBITDA margin of approximately 84%. The company generated $869 million in net cash from operating activities and $863.3 million in free cash flow during the quarter.

On the earnings call, CEO Adam Foroughi attributed the revenue shortfall primarily to timing. He explained that the pace of meaningful advertising model improvement was lighter than normal during the June quarter, and that the next significant model upgrade landed just after the quarter ended. “This quarter came down to timing,” Foroughi said. The company noted there was no indication of weaker advertiser demand or changes in the competitive landscape. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

For Q3 2026, AppLovin guided for revenue of $2.055 billion to $2.085 billion—implying 46% to 48% year-over-year growth—and adjusted EBITDA of $1.71 billion to $1.74 billion with an 83% margin. The revenue midpoint of approximately $2.07 billion came in modestly below the $2.08 billion Street consensus, adding to investor unease.

Market Reaction and Investor Sentiment

The market’s response to AppLovin’s Q2 report was swift and severe. Shares tumbled approximately 16% to 20% in after-hours trading following the August 5 release, with some reports indicating an intraday after-hours decline exceeding 24%. The magnitude of the selloff far exceeded the size of the revenue miss, suggesting investors were recalibrating growth expectations rather than simply reacting to a $20 million shortfall.

Prior to the report, AppLovin shares had already declined roughly 38% year-to-date, underperforming the broader market. The post-earnings drop pushed the stock toward or below its 52-week lows. Despite delivering 53% revenue growth and 55% net income growth—figures most companies would celebrate—the combination of a rare revenue miss and a forward guidance midpoint below consensus was enough to trigger significant repositioning among institutional and retail investors alike.

Forward Outlook and Key Factors to Monitor

Looking ahead, the central question for AppLovin investors is whether the Q2 revenue miss was a one-time timing issue, as management characterized it, or an early signal of decelerating momentum. CEO Adam Foroughi stated that the next advertising model improvement went live shortly after the quarter ended and is already contributing to third-quarter performance, with guidance reflecting 46% to 48% year-over-year revenue growth.

One critical factor to monitor is the continued expansion of AppLovin’s consumer and e-commerce advertising vertical. Management disclosed that advertiser spending in this category reached a new record in Q2, finishing 28% above Q4 2025 levels despite the seasonally slower period. While the gaming business remains the dominant revenue driver, the consumer advertising segment’s trajectory could increasingly diversify and stabilize overall growth over time.

Investors should also keep an eye on compute and infrastructure costs. CFO Matt Stumpf noted that higher compute spending was the primary driver of sequential cost increases, and the company intends to continue investing in model development when it can generate incremental revenue. Adjusted EBITDA margins are expected to remain in the low-80% range longer term, though near-term fluctuations are possible as infrastructure investments ramp up.

Finally, capital allocation remains a notable element of the AppLovin story. With approximately $1.8 billion remaining under its share repurchase authorization and net leverage at just 0.1 times trailing 12-month adjusted EBITDA, the company retains significant flexibility. The pace and scale of buybacks, alongside any strategic moves in consumer advertising or adjacent markets, will be important indicators of management’s confidence in the growth trajectory.

Exploring AI-Powered Research Tools

In my analysis of earnings like these, I often turn to Tickeron’s AI Screener to quickly filter stocks by fundamentals, technical patterns, and industry signals. It helps surface comparable names in ad tech and highlights momentum shifts that might otherwise take hours to identify manually. The tool has become a regular part of my workflow when evaluating post-earnings moves and sector peers.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: APP

APP's RSI Oscillator ascending out of oversold territory

The RSI Oscillator for APP moved out of oversold territory on July 27, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 21 similar instances when the indicator left oversold territory. In of the 21 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 51 cases where APP's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on August 05, 2026. You may want to consider a long position or call options on APP as a result. In of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for APP just turned positive on August 04, 2026. Looking at past instances where APP's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where APP advanced for three days, in of 342 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

APP moved below its 50-day moving average on July 10, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for APP crossed bearishly below the 50-day moving average on July 15, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 9 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where APP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

APP broke above its upper Bollinger Band on July 01, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for APP entered a downward trend on August 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. APP’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (44.444) is normal, around the industry mean (48.272). P/E Ratio (32.114) is within average values for comparable stocks, (45.845). Projected Growth (PEG Ratio) (1.149) is also within normal values, averaging (4.571). APP has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.045). P/S Ratio (20.747) is also within normal values, averaging (28.884).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are Trade Desk (The) (NASDAQ:TTD).

Industry description

Making a brand known to people, garnering more clients/consumers for its product and solidifying the brand’s position in an industry – all of these are essential to a company’s growth, and that’s where marketing/advertising come in as one of the key catalysts. Advertising industry is a global multibillion-dollar business of public relations and marketing companies, media services and advertising agencies – entities that help to connect manufacturers/producers with customers. Digital media has played a big role in the growth of global advertising, and agencies invest substantially to integrate advanced technologies into their business operations. According to some estimates, the U.S. advertising industry is expected to generate revenue of $52.6 billion by 2023, up from almost $40 billion in 2015 . Omnicom Group Inc., Trade Desk, Inc. and Interpublic Group of Companies, Inc. are some of the major U.S. companies in the industry.

Market Cap

The average market capitalization across the Advertising/Marketing Services Industry is 4.96B. The market cap for tickers in the group ranges from 10.35K to 140.36B. APP holds the highest valuation in this group at 140.36B. The lowest valued company is MMND at 10.35K.

High and low price notable news

The average weekly price growth across all stocks in the Advertising/Marketing Services Industry was 1%. For the same Industry, the average monthly price growth was -6%, and the average quarterly price growth was 6%. MF experienced the highest price growth at 37%, while CRTO experienced the biggest fall at -25%.

Volume

The average weekly volume growth across all stocks in the Advertising/Marketing Services Industry was -19%. For the same stocks of the Industry, the average monthly volume growth was -10% and the average quarterly volume growth was -14%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 54
P/E Growth Rating: 68
Price Growth Rating: 56
SMR Rating: 88
Profit Risk Rating: 95
Seasonality Score: -11 (-100 ... +100)
View a ticker or compare two or three
APP
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry AdvertisingMarketingServices

Profile
Details
Industry
N/A
Address
1100 Page Mill Road
Phone
+1 800 839-9646
Employees
898
Web
https://www.applovin.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.